CXCL9 chemokine level is associated with spontaneous clearance and sustained virological response in Egyptian Chronic Hepatitis C patients receiving direct acting antivirals-Reference-Cited by-同舟云学术

CXCL9 chemokine level is associated with spontaneous clearance and sustained virological response in Egyptian Chronic Hepatitis C patients receiving direct acting antivirals

Published:2020-07-09 Issue:2 Volume:28 Page:141-148
ISSN:1875-869X
Container-title:Human Antibodies
language:
Short-container-title:HAB

Author:

Tabll Ashraf A.¹,Afifi Mamdouh S.²,El-Etrawy Abd-Allah S.³,El-Kousy Salah M.²,Smolic Martina⁴,El Abd Yasmine S.¹

Affiliation:

1. Microbial Biotechnology Department, Genetic Engineering and Biotechnology Research Division National Research Centre, Giza, Egypt

2. Chemistry Department, Faculty of Science, Menufia University, Menufia, Egypt

3. Chemistry Department, Basic Science Center and Pharmaceutical Organic Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th October City, Egypt

4. Department of Pharmacology, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia

Publisher

IOS Press

Subject

General Medicine,Immunology,Immunology and Allergy

Reference33 articles.

1. Viral hepatitis and the Global Burden of Disease: A need to regroup;Cooke;J Viral Hepat,2013

2. Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence;Rehermann;J Clin Invest,2009

3. Chronic hepatitis C virus (HCV) disease burden and cost in the United States;Razavi;Hepatology,2013

4. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

5. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV;Mohd Hanafiah;Hepatology,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C;Cytokine;2024-04